RxDoctor Payments Data

Sourabh Mukherjee, MD

Vascular Surgery · Hattiesburg, MSNPI 1598983108

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,890 of the $6,665 with a category attached, or 88.4%. 21 manufacturers reported payments, led by Endologix LLC at 45.4% of the total. That places this record below the midpoint for vascular surgery clinicians in MS, where the typical reported total is $7,056.

$6,665in general payments, 2019–2025

Across 103 payments — averaging $64.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Endologix LLC$3K
  • Silk Road Medical, Inc.$1K
  • Medtronic$1K
  • W. L. Gore & Associates, Inc.$217
  • Penumbra, Inc.$190
  • Boston Scientific$171
  • plus $595 from 15 others

What the payments were for

  • Travel & lodging$67910%
  • Food & beverage$5,89088%
  • Education$961%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,665 in reported general payments places this provider in the 45th percentile of 39 vascular surgery providers in Mississippi.

See all vascular surgery providers in Mississippi

Medicare billing

Part B allowed, 2024
$793,678
Medicare patients
684
Services billed
9,913

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban51$35,101
XareltoRivaroxaban48$28,331
Cilostazol216$3,287
ClopidogrelClopidogrel Bisulfate403$2,927
Atorvastatin Calcium166$683
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen35$351
Rosuvastatin Calcium53$286
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$179
Ezetimibe11$135
Diazepam12$6

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$166$28,33148 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 39 vascular surgery providers in Mississippi.

Other vascular surgery in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →